ABP – abpro holdings, inc (US:NASDAQ)

News

Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Abpro (NASDAQ:ABP) was downgraded by analysts at Wall Street Zen to a
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager
Abpro (NASDAQ:ABP) had its "hold" rating reaffirmed by analysts at Maxim Group.
Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com